Skip to main content
. 2012 Nov 23;54(2):322–329. doi: 10.1093/jrr/rrs108

Table 3.

The results of the univariate analyses of factors predicting the survival rates

Variable Pt. (n) Overall survival rate
Progression-free survival rate
Local (in-field) control rate
2-year (%) P 2-year (%) P 2-year (%) P
Performance status
 0–1 22 46 0.17 38 0.83 95 0.27
 2 5 80 40 100
Tumor size
 <3 cm 11 88 0.0013 64 0.016 100 0.41
 ≥3 cm 16 29 22 93
Irradiated lesion
 One lesion 19 52 0.28 38 0.79 100 0.11
 Two lesions 8 54 43 86
Period between start of first-line treatment and RT
 <2 years 16 35 0.023 19 0.088 93 0.40
 ≥2 years 11 80 64 100
Total dose of radiation (BED, Gy10)
 <72 13 49 0.72 51 0.11 92 0.68
 ≥72 14 57 26 100
Concurrent chemotherapy
 Yes 6 0 0.31 NR 0.23 100 NR
 No 21 57 42 95
Hyperthermia
 Yes 7 0 0.89 NR 0.73 100 NR
 No 20 56 42 95
Objective tumor response
 CR 11 89 0.0044 67 0.013 100 0.079
 PR or NC 16 28 21 93
Response to chemotherapy immediately before RT
 PR 5 100 0.019 80 0.069 100 NR
 NC or PD 15 47 34 100

BED = biologically effective dose; NR = not reached; CR = complete response; PR = partial response; NC = no change.